[{"address1": "116 Huntington Avenue", "address2": "Suite 703", "city": "Boston", "state": "MA", "zip": "02116", "country": "United States", "phone": "617 468 4219", "website": "https://www.bicara.com", "industry": "Biotechnology", "industryKey": "biotechnology", "industryDisp": "Biotechnology", "sector": "Healthcare", "sectorKey": "healthcare", "sectorDisp": "Healthcare", "longBusinessSummary": "Bicara Therapeutics Inc., a clinical-stage biopharmaceutical company, engages in the development of bifunctional therapies for solid tumors. Its lead program is ficerafusp alfa, a bifunctional antibody that combines a clinically validated epidermal growth factor receptor directed monoclonal antibody with a domain that binds to human transforming growth factor beta for the treatment of solid tumors. The company was incorporated in 2018 and is based in Boston, Massachusetts.", "fullTimeEmployees": 55, "companyOfficers": [{"maxAge": 1, "name": "Dr. Claire  Mazumdar Clemon M.B.A., Ph.D.", "age": 35, "title": "CEO & Director", "yearBorn": 1989, "fiscalYear": 2024, "totalPay": 829800, "exercisedValue": 0, "unexercisedValue": 5023506}, {"maxAge": 1, "name": "Mr. Ryan  Cohlhepp Pharm.D.", "age": 47, "title": "President, COO & Director", "yearBorn": 1977, "fiscalYear": 2024, "totalPay": 825750, "exercisedValue": 0, "unexercisedValue": 2526259}, {"maxAge": 1, "name": "Mr. Ivan  Hyep M.B.A.", "age": 39, "title": "Chief Financial Officer", "yearBorn": 1985, "fiscalYear": 2024, "totalPay": 915375, "exercisedValue": 0, "unexercisedValue": 1986752}, {"maxAge": 1, "name": "Ms. Lara S. Meisner J.D.", "age": 51, "title": "Chief Legal Officer & Corporate Secretary", "yearBorn": 1973, "fiscalYear": 2024, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Ms. Pauline  Dufresne", "title": "Chief People Officer", "fiscalYear": 2024, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Ms. Rachel  Salazar", "title": "SVP of R&D Strategy and Operations", "fiscalYear": 2024, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Ms. Sathish  Hasige Ph.D.", "title": "Senior VP and Head of Technical Operations & Supply Chain", "fiscalYear": 2024, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Dr. David  Raben M.D.", "age": 61, "title": "Chief Medical Officer", "yearBorn": 1963, "fiscalYear": 2024, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Ms. Angela  Windt", "title": "VP & Head of Regulatory Affairs", "fiscalYear": 2024, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Dr. Jeltje  Schulten M.B.A., M.D.", "title": "Senior Vice President of Clinical & Medical Affairs", "fiscalYear": 2024, "exercisedValue": 0, "unexercisedValue": 0}], "auditRisk": 9, "boardRisk": 8, "compensationRisk": 9, "shareHolderRightsRisk": 8, "overallRisk": 9, "governanceEpochDate": 1764547200, "compensationAsOfEpochDate": 1735603200, "executiveTeam": [], "maxAge": 86400, "priceHint": 2, "previousClose": 18.76, "open": 18.9, "dayLow": 18.18, "dayHigh": 19.18, "regularMarketPreviousClose": 18.76, "regularMarketOpen": 18.9, "regularMarketDayLow": 18.18, "regularMarketDayHigh": 19.18, "payoutRatio": 0.0, "trailingPE": 3.3828998, "forwardPE": -11.304348, "volume": 695818, "regularMarketVolume": 695818, "averageVolume": 664977, "averageVolume10days": 705340, "averageDailyVolume10Day": 705340, "bid": 13.64, "ask": 23.16, "bidSize": 2, "askSize": 2, "marketCap": 997031552, "fiftyTwoWeekLow": 7.8, "fiftyTwoWeekHigh": 22.675, "allTimeHigh": 28.09, "allTimeLow": 7.8, "fiftyDayAverage": 16.4748, "twoHundredDayAverage": 13.01955, "trailingAnnualDividendRate": 0.0, "trailingAnnualDividendYield": 0.0, "currency": "USD", "tradeable": false, "enterpriseValue": 708839488, "profitMargins": 0.0, "floatShares": 24280456, "sharesOutstanding": 54781950, "sharesShort": 7218989, "sharesShortPriorMonth": 5679088, "sharesShortPreviousMonthDate": 1760486400, "dateShortInterest": 1763078400, "sharesPercentSharesOut": 0.1318, "heldPercentInsiders": 0.12142, "heldPercentInstitutions": 0.91813004, "shortRatio": 9.47, "shortPercentOfFloat": 0.2057, "impliedSharesOutstanding": 54781950, "bookValue": 7.375, "priceToBook": 2.4677968, "lastFiscalYearEnd": 1735603200, "nextFiscalYearEnd": 1767139200, "mostRecentQuarter": 1759190400, "netIncomeToCommon": -121521000, "trailingEps": 5.38, "forwardEps": -1.61, "enterpriseToEbitda": -5.026, "52WeekChange": -0.1125828, "SandP52WeekChange": 0.13287461, "quoteType": "EQUITY", "currentPrice": 18.2, "targetHighPrice": 48.0, "targetLowPrice": 11.0, "targetMeanPrice": 32.57143, "targetMedianPrice": 36.0, "recommendationMean": 1.44444, "recommendationKey": "strong_buy", "numberOfAnalystOpinions": 7, "totalCash": 290167008, "totalCashPerShare": 5.297, "ebitda": -141042000, "totalDebt": 1975000, "quickRatio": 13.799, "currentRatio": 14.142, "debtToEquity": 0.49, "returnOnAssets": -0.18591, "returnOnEquity": -0.26639998, "freeCashflow": -75155376, "operatingCashflow": -112980000, "grossMargins": 0.0, "ebitdaMargins": 0.0, "operatingMargins": 0.0, "financialCurrency": "USD", "symbol": "BCAX", "language": "en-US", "region": "US", "typeDisp": "Equity", "quoteSourceName": "Nasdaq Real Time Price", "triggerable": true, "customPriceAlertConfidence": "HIGH", "shortName": "Bicara Therapeutics Inc.", "longName": "Bicara Therapeutics Inc.", "marketState": "CLOSED", "hasPrePostMarketData": true, "firstTradeDateMilliseconds": 1726234200000, "postMarketChangePercent": 0.0, "postMarketPrice": 18.2, "postMarketChange": 0.0, "regularMarketChange": -0.559999, "regularMarketDayRange": "18.18 - 19.18", "fullExchangeName": "NasdaqGM", "averageDailyVolume3Month": 664977, "fiftyTwoWeekLowChange": 10.400001, "fiftyTwoWeekLowChangePercent": 1.3333334, "fiftyTwoWeekRange": "7.8 - 22.675", "fiftyTwoWeekHighChange": -4.4749985, "fiftyTwoWeekHighChangePercent": -0.19735385, "fiftyTwoWeekChangePercent": -11.25828, "earningsTimestamp": 1762781400, "earningsTimestampStart": 1762781400, "earningsTimestampEnd": 1762781400, "isEarningsDateEstimate": false, "epsTrailingTwelveMonths": 5.38, "epsForward": -1.61, "epsCurrentYear": -2.48571, "exchange": "NGM", "messageBoardId": "finmb_674698236", "exchangeTimezoneName": "America/New_York", "exchangeTimezoneShortName": "EST", "gmtOffSetMilliseconds": -18000000, "market": "us_market", "esgPopulated": false, "corporateActions": [], "postMarketTime": 1764975350, "regularMarketTime": 1764968401, "priceEpsCurrentYear": -7.321852, "fiftyDayAverageChange": 1.7252007, "fiftyDayAverageChangePercent": 0.104717545, "twoHundredDayAverageChange": 5.1804504, "twoHundredDayAverageChangePercent": 0.3978978, "sourceInterval": 15, "exchangeDataDelayedBy": 0, "ipoExpectedDate": "2024-09-13", "averageAnalystRating": "1.4 - Strong Buy", "cryptoTradeable": false, "regularMarketChangePercent": -2.98507, "regularMarketPrice": 18.2, "displayName": "Bicara Therapeutics", "trailingPegRatio": null, "__fetch_time": "2025-12-06"}]